The Jackson Laboratory

Register for our webinar:
De-Risk Therapeutic Antibody Drug Development Using Humanized FcRn Mice

September 19, 2019, 4:00 PM Central European Time (Convert this time to your time zone)


Do you need reliable pharmacokinetic (PK) data to evaluate human immunoglobulin or albumin-based therapeutic drug candidates? The humanized FcRn (Hu-FcRn) mouse model enables you to obtain clinically-relevant PK data related to drug half-life. This critically important PK data helps optimize the design of preclinical efficacy studies and to de-risk lead selection. Join this webinar to learn about: 
  • The biology of FcRn and its impact on immunoglobulin and albumin half-life
  • The advantages of Hu-FcRn models for immunoglobulin-based therapeutic lead selection
  • Selecting and using specific variants of Hu-FcRn models for drug evaluation
  • Designing a pharmacokinetic study with Hu-FcRn models based on in vivo data of several therapeutics

JAX™ Webinars are complimentary.
No fees will be charged for registering.

When registering, please use an institutional email address or contact our webinar staff to request an exception. Thank you.

Fields marked with (*) are mandatory.

Subscribe to the JAX™ Webinar mailing list to receive monthly announcements about upcoming complimentary webinars (2-4 each month) on current and cutting edge topics related to using mouse models in biomedical research.

Have an immediate question? Contact us at [email protected] or call 1.800.422.6423 (US) or 1.207.288.5845 (International).